Loading organizations...
Key people at India Life Sciences Fund III.
India Life Sciences Fund III was founded in 2019 by Vishy Chebrol (Co-Founder, Chief Investment Officer and Managing Director) and Hari Buggana (Founder, Chairman and Managing Director).
India Life Sciences Fund III is a private equity fund managed by InvAscent, based in Cybercity, Ebene, Mauritius, specializing in providing growth capital to established companies across India's pharmaceuticals, healthcare delivery, medical technology, animal health, nutraceuticals, and healthtech sectors. The fund closed at its hard cap of $250 million in commitments in 2018, deploying equity into firms to support their expansion initiatives and market penetration. It operates as part of InvAscent's family of India Life Sciences Funds, which collectively manage over $800 million in assets across more than 38 companies. Its portfolio includes notable firms such as Intron Life Sciences, Strides Consumer, Gland Pharma, Healthcare Global, and Dr Agarwals’ Eye Hospital. InvAscent, the fund's manager, was founded in 2005. The firm focuses on pharmaceuticals, healthcare delivery, medical devices, animal health, nutraceuticals, and healthtech companies based in India.
India Life Sciences Fund III was founded in 2019 by Vishy Chebrol (Co-Founder, Chief Investment Officer and Managing Director) and Hari Buggana (Founder, Chairman and Managing Director).
Key people at India Life Sciences Fund III.
India Life Sciences Fund III has 1 tracked investment across 1 company. The latest tracked deal is $130.0M Series C in MediBuddy in February 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2022 | MediBuddy | $130.0M Series C | Tejasvi Ravi, DR. Amit Varma | Bessemer Venture Partners, FinSight Ventures, Alteria Capital, InnoVen Capital, JAFCO Asia, Rebright Partners, Stride Ventures, Teamfund |
